ZERO For Life's
Gluten-Free
Food Label Interpreter
Visit zeroforlife.com to learn more about celiac disease.
THE IMPORTANCE OF SCRUTINIZING FOOD LABELS FOR CELIAC DISEASE
For individuals with celiac disease, wheat allergy, or other gluten-related disorders, the simple act of eating can be fraught with challenges. The key to managing these conditions and preventing long-term health consequences lies in strict adherence to a gluten-free diet. However, this is easier said than done, largely due to the complexities of food labeling regulations in the United States.
In the USA, food labeling laws can be confusing, especially for those with celiac disease. If a manufacturer chooses to voluntarily label their product as “gluten-free”, the manufacturer must be able to confirm that the gluten content is below the legally defined “<20 PPM” threshold set by the FDA.
However, unless a product is explicitly marked “gluten-free,” there is no assurance that a manufacturer is complying with gluten-free food labeling laws or that it has been tested to verify the absence of gluten. Manufacturers aren’t required to call out gluten in the ingredient list, only the top 9 allergens. While wheat is considered one of the top 9 allergens, the other sources of gluten (namely barley and rye) are not and can be a hidden source of gluten.
Additionally, manufacturers are not required to inform if the ingredients used or the final product were cross-contaminated during harvesting, transportation, manufacturing, or storage. This lack of transparency can leave individuals with celiac disease vulnerable to inadvertent gluten exposure.
ZERO For Life does not recommend individuals with celiac disease consume products containing any gluten-containing ingredient (i.e., Wheat, Barley, or Rye) in amounts above 0.01 ppm (i.e., 0.011 mg of gluten per day) which was determined by the FDA as “the lowest gluten and most conservative [Level of Concern] (LOC) value associated with a [Tolerable Daily Intake Level] (TDI) that was estimated to (1) Be protective of the vast majority of individuals with celiac disease ages 1 year and older, including those most sensitive to gluten and (2) not cause clinical, morphological, and/or physiological adverse health effects.”
Despite the FDA’s determinations, the Agency set the legal gluten threshold at approximately 2,000 times higher – citing a number of factors influencing their decisions “such as ‘‘ease of compliance and enforcement, stakeholder concerns (i.e., industry, consumers, and other interested parties), economics (e.g., cost/benefit analysis), trade issues, and legal authorities’’ (Ref. 1 at p. 45 and 72 FR 2795 at 2800).”
Those thresholds, however, have not been proven to be safe for individuals with celiac disease. Authors of studies like one used to determine the current legal gluten threshold (Catassi, et al., 2007) have even been quoted as stating, “These results confirm that an abnormal small-bowel morphology persists in a significant proportion of CD patients treated with a GFD, despite full resolution of their symptoms. This finding has been shown to be related to the ongoing ingestion of gluten, either deliberate or inadvertent, causing persistent inflammation in the small-intestinal mucosa… Because of the limited number of patients, we were not able to reach firm conclusions about the potential toxicity of 10 mg gluten/d, which remained a “gray” area.”
The damage caused by the continual ingestion of gluten can lead to a range of long-term health consequences. Failure to adhere strictly to a truly gluten-free diet, containing approximately zero parts per million, can result in complications such as nutrient deficiencies, osteoporosis, infertility, neurological problems, and an increased risk of certain cancers. Some studies have even shown that individuals with celiac disease are not living longer lives despite adhering to a “gluten-free” diet. These facts underscore the belief that trace amounts of gluten, which are currently permitted by the US government in foods labeled “gluten-free,” are still too much.
In conclusion, the importance of reading food labels cannot be overstated for individuals with celiac disease. The potential long-term consequences of not strictly adhering to a genuinely gluten-free diet are significant, making it crucial for those with celiac disease to stay well-informed, vigilant, and proactive in managing their condition. The best way to do so is to familiarize oneself with the food labeling laws, use tools such as ZERO For Life’s Gluten-Free Food Label Interpreter, and when in doubt, throw it out!
References:
- Applied Nutrition Food (no date) “Health hazard assessment for gluten exposure in individuals with celiac disease: Determination of tolerable daily intake levels and levels of concern for gluten,” Fda.gov. Available at: https://www.fda.gov/media/81500/download (Accessed: September 13, 2023).
- Campagna, G. et al. (2017) “The progression of coeliac disease: its neurological and psychiatric implications,” Nutrition research reviews, 30(1), pp. 25–35. doi: 10.1017/s0954422416000214.
- Catassi, C. et al. (2007) “A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease,” The American journal of clinical nutrition, 85(1), pp. 160–166. doi: 10.1093/ajcn/85.1.160.
- Ch’ng, C. L., Jones, M. K. and Kingham, J. G. C. (2007) “Celiac disease and autoimmune thyroid disease,” Clinical medicine & research, 5(3), pp. 184–192. doi: 10.3121/cmr.2007.738.
- Dore, M. P. et al. (2022) “Autoimmune thyroid disorders are more prevalent in patients with celiac disease: A retrospective case-control study,” Journal of clinical medicine, 11(20), p. 6027. doi: 10.3390/jcm11206027.
- Enaud, R. et al. (2022) “Compliance with gluten free diet is associated with better quality of life in celiac disease,” Nutrients, 14(6), p. 1210. doi: 10.3390/nu14061210.
- Falcomer, A. L. et al. (2020) “Gluten contamination in food services and industry: A systematic review,” Critical reviews in food science and nutrition, 60(3), pp. 479–493. doi: 10.1080/10408398.2018.1541864.
- Food allergies (2023) U.S. Food and Drug Administration. FDA. Available at: https://www.fda.gov/food/food-labeling-nutrition/food-allergies (Accessed: September 13, 2023).
- Gluten and food labeling (2022) U.S. Food and Drug Administration. FDA. Available at: https://www.fda.gov/food/nutrition-education-resources-materials/gluten-and-food-labeling (Accessed: September 13, 2023).
- Gluten free certification (no date) Brcgs.com. Available at: https://www.brcgs.com/our-standards/gluten-free-certification/ (Accessed: September 13, 2023).
- Gluten-free certification (no date) NSF. Available at: https://www.nsf.org/food-beverage/food-beverage-product-certification/gluten-free-certification (Accessed: September 13, 2023).
- Gluten-free certification, manufacturing (2020) Gluten-Free Food Program. Available at: https://glutenfreefoodprogram.com/gluten-free-certification-manufacturing/ (Accessed: September 16, 2023).
- Gluten-Free Certification Organization. (2020) GFCO. Available at: https://gfco.org/ (Accessed: September 13, 2023).
- Guennouni, M. et al. (2022) “Gluten contamination in labelled gluten-free, naturally gluten-free and meals in food services in low-, middle- and high-income countries: a systematic review and meta-analysis,” The British journal of nutrition, 127(10), pp. 1528–1542. doi: 10.1017/s0007114521002488.
- “Food Labeling; Gluten-Free Labeling of Foods; Reopening of the Comment Period,” Govinfo.gov. Available at: https://www.govinfo.gov/content/pkg/FR-2011-08-03/pdf/2011-19620.pdf (Accessed: September 13, 2023).
- Kalra, N. et al. (2022) “Current updates on the association between celiac disease and cancer, and the effects of the gluten‑free diet for modifying the risk (Review),” International Journal of Functional Nutrition, 3(1). doi: 10.3892/ijfn.2022.25.
- Kornberg, A. et al. (2023) “Gluten induces rapid reprogramming of natural memory αβ and γδ intraepithelial T cells to induce cytotoxicity in celiac disease,” Science immunology, 8(85). doi: 10.1126/sciimmunol.adf4312.
- Kreutz, J. M. et al. (2020) “Narrative review: Nutrient deficiencies in adults and children with treated and untreated celiac disease,” Nutrients, 12(2), p. 500. doi: 10.3390/nu12020500.
- Lebwohl, B. et al. (2020) “Association between celiac disease and mortality risk in a Swedish population,” JAMA: the journal of the American Medical Association, 323(13), p. 1277. doi: 10.1001/jama.2020.1943.
- Lebwohl, B. et al. (2021) “Risk of skin disorders in patients with celiac disease: A population-based cohort study,” Journal of the American Academy of Dermatology, 85(6), pp. 1456–1464. doi: 10.1016/j.jaad.2020.10.079.
- Martín-Masot, R. et al. (2023) “Celiac disease is a risk factor for mature T and NK cell lymphoma: A Mendelian randomization study,” International journal of molecular sciences, 24(8), p. 7216. doi: 10.3390/ijms24087216.
- Mayassi, T. et al. (2019) “Chronic inflammation permanently reshapes tissue-resident immunity in celiac disease,” Cell, 176(5), pp. 967-981.e19. doi: 10.1016/j.cell.2018.12.039.
- Patel, S. C. et al. (2021) “Celiac disease, beyond the bowel: A review of its neurological manifestations,” Cureus, 13(12). doi: 10.7759/cureus.20112.
- Questions and answers on the gluten-free food labeling final rule (2022) U.S. Food and Drug Administration. FDA. Available at: https://www.fda.gov/food/food-labeling-nutrition/questions-and-answers-gluten-free-food-labeling-final-rule (Accessed: September 13, 2023).
- Rodríguez, J. M. et al. (2022) “Commercial oats in gluten-free diet: A persistent risk for celiac patients,” Frontiers in nutrition, 9. doi: 10.3389/fnut.2022.986282.
- Sharma, N. et al. (2020) “Pathogenesis of celiac disease and other gluten related disorders in wheat and strategies for mitigating them,” Frontiers in nutrition, 7. doi: 10.3389/fnut.2020.00006.
- Syage, J. A. et al. (2018) “Determination of gluten consumption in celiac disease patients on a gluten-free diet,” The American journal of clinical nutrition, 107(2), pp. 201–207. doi: 10.1093/ajcn/nqx049.
- Therrien, A., Kelly, C. P. and Silvester, J. A. (2020) “Celiac disease: Extraintestinal manifestations and associated conditions,” Journal of clinical gastroenterology, 54(1), pp. 8–21. doi: 10.1097/mcg.0000000000001267.
- Thompson, T. (2017) Does wheat starch belong in a gluten-free diet?, Gluten Free Watchdog. Available at: https://www.glutenfreewatchdog.org/news/does-wheat-starch-belong-in-a-gluten-free-diet/ (Accessed: September 13, 2023).
- Thompson, T. (2020) What the FDA has to say about wheat starch and hydrolyzed gluten, Gluten Free Watchdog. Available at: https://www.glutenfreewatchdog.org/news/what-the-fda-has-to-say-about-wheat-starch-and-hydrolyzed-gluten/ (Accessed: September 13, 2023).
- Thompson, T. (2023) Wheat starch in gluten-free foods in 2023: An update from, Gluten Free Watchdog. Available at: https://www.glutenfreewatchdog.org/news/wheat-starch-in-gluten-free-foods-in-2023-an-update-from-gluten-free-watchdog/ (Accessed: September 13, 2023).